Implantable hormonal and emergency contraception

Current Opinion in Obstetrics and Gynecology

Volumn 9, Issue 3, 1997, Pages 169-174

  Cullins, Vanessa E ^a   Garcia, Francisco A R ^a  

^a JOHNS HOPKINS BAYVIEW MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LEVONORGESTREL;

ARTICLE; CONTRACEPTION; DRUG EFFICACY; DRUG SAFETY; EMERGENCY MEDICINE; HUMAN; LAW SUIT; PRIORITY JOURNAL;

EID: 0030856496     PISSN: 1040872X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001703-199706000-00006     Document Type: Article

References (44)

1. The Population Council in collaboration with the INTERCARE consulting network: Norplant, Levonorgestrel Implants: a Summary of Scientific Data. New York: The Population Council; 1990.
2. R contraceptives. Stud Fam Planning 1988, 19:81-94.
3. Population Reports: Decisions for Norplant programs. Implants Injectables 1992, K4:1-31.
4. Speroff L, Darney P: Implant contraception: Norplant In A Clinical Guide for Contraception, edn 2. Williams and Wilkins: Baltimore; 1996:129-174.
5. Kolata G: Will lawyers kill off Norplant? New York Times 1995, final section 3, p1.
6. Lewin T: 'Dream' contraceptive's nightmare.' New York Times 1994, final section A, p10.
7. Lewin T: Fears, suites and regulations stall contraceptive advances. New York Times 1995, final section A, p1.
8. Ronald A: Physicians Desk Reference. Medical Economics Company: Montvale, NJ; 1997:1907-1921,1928-1936,2580-2586,2852-2859,2863-2867,2867-2872.
9. R compared with oral contraceptive use among adolescents.
10. R use and subsequent condom use.
11. Cullins VE, Remsburg RE, Blumenthal PD, Huggins GR: Comparison of adolescent and adult experiences with Norplant levonorgestrel contraceptive implants. Obstet Gynecol 1994, 83:1026-1032.
12. Rizk DEE: Subdermal levonorgestrel implants. Three years' experience in Cairo, Egypt J Reprod Med 1995, 40:638-644.
13. Hatasaka H: Implantable levonorgestrel contraception: 4 years of experience with Norplant Clin Obstet Gynecol 1995, 38:859-871.
14. Polaneczky M, Slap G, Forke C, Rappaport A, Sondheimer S: The use of levonorgestrel implants (Norplant) for contraception in adolescent mothers. N Engl J Med 1994, 331:1201-1206.
15. Blumenthal PD, Wilson LE, Remsburg RE, Cullins VE, Muggins GR: Contraceptive outcomes among post-partum and post-abortal adolescents. Contraception 1994, 50:451-460.
16. Dinerman LM, Wilson MD, Duggan AK, Joffe A: Outcomes of adolescents using levonorgestrel implants vs oral contraceptives or other contraceptive methods. Arch Pediatr Adolesc Med 1995, 149:967-972.
17. Rainey DY, Parsons LH, Kenney PG, Krowchuk DP: Compliance with return appointments for reproductive health care among adolescent Norplant users. J Adolesc Health 1995, 16:385-388. A retrospective descriptive study of adolescents that documents that noncompliance with health maintenance return visits does not differ by contraceptive method chosen. Compliance is poor, regardless.
18. Creinin MD, Klaisle CM: Case report Removal of levonorgestrel capsules from the biceps muscle, Int J Gynecol Obstet 1995, 50:189-191.
19. Pies CA: Norplant use by adolescents: viewpoints of three takeholder groups. J Adolesc Health 1995, 16:405-411. This outstanding qualitative research defines issues of interest and concerns of various stakeholder groups. The author emphasizes the need for provider, consumer, and policy maker dialogue before the introduction of any medical method that may be misperceived.
20. Cromer BA, Smith RD, Blair JMCA, Dwyer J, Brown RT: A prospective study of adolescents who choose among levonorgestrel implant (Norplant), medroxyprogesterone acetate (Depo-Provera), or the combined oral contraceptive pill as contraception. Pediatrics 1994, 94:687-694.
21. R can be safely inserted immediately postpartum.
22. Twenty-third Ortho Annual Birth Control Study. Ortho Pharmaceuticals; 1991.
23. Kost K, Forrest D. American women's sexual behaviour and exposure to risk of sexually transmitted diseases. Fam Plan Perspect 1992, 24:244.
24. Harlap S, Kost K, Forrest JD: Preventing Pregnancy, Protecting Health. Alan Gutmacher Inst: New York; 1991:33-38.
25. Glasier AB, Ketting E, Palan VT, Brown L, Kaur S, Bilian X, Garza-Flores J, Estrada LV, Deland G, Fayoye G et al. Case studies in emergency contraception from six countries, Int Fam Plan Perspect 1996, 22:57-61.
26. Grossman RA, Grossman BD: How frequently is emergency contraception used? Fam Plan Perspect 1994, 173:1438-1445.
27. Harper CC, Ellertson CE: The emergency contraceptive pill: a survey of knowledge and attitudes among students at Princeton University. Am J Obstet Gynecol 1995, 173:1438-1445.
28. Yuzpe AA, Lanier WJ: Ethinyl estradiol and dl-norgestrel as a postcoital contraceptive. Fertil Steril 1977, 28:932-936.
29. American College of Obstetrics and Gynecology: Emergency oral contraception. Am Coll Obstet Gynecol Pract Patterns 1996, 31:1-8. This document contains evidence-based practice guidelines and a review of the existing literature about the Yuzpe method.
30. Grou F, Rodrigues I: The morning-after pill-how long after? Am J Obstet Gynecol 1995, 171:1529-1534.
31. Trussel J, Ellertson C, Stewart F: The effectiveness of the Yuzpe regimen of emergency contraception. Fam Plan Perspect 1996. 28:58-64.
32. Trussel J, Ellertson C, Rodrigues G: The Yuzpe regimen of emergency contraception: how long after the morning after? Obstet Gynecol 1996, 88:150-154.
33. Van Hertzen H, Van Look PFA: Research on new methods of emergency contraception. Fam Plan Perspect 1996, 28:52-57, 58. A review of the mechanisms of action of various emerging postcoital contraceptive technologies.
34. Wilson JG, Brent RL: Are female sex hormones teratogenic?. Am J Obstet Gynecol 1981, 141:567-580.
35. Ellertson C: History and efficacy of emergency contraception. Fam Plan Perspect 1996, 28:44-48. The historical development of emergency contraception.
36. Cayley J: Emergency contraception: time to loosen medical controls over its availability. BMJ 1995, 311:762-763.
37. International Medical Advisory Panel of the International Planned Parenthood Federation: Statement on emergency contraception, Int Planned Parenthood Med Bull 1994, 26:1-2.
38. Blumenthal P, Mclntosh N: Emergency contraception. In Pocketguide for Family Planning Service Providers, edn 3. Edited by Oliveras E. Baltimore: JHPIEGO Corporation; 1996:65-72.
39. Trussel J, Stewart F: The effectiveness of postcoital hormonal contraception. Fam Plan Perspect 1992, 24:262-264.
40. Webb AMC, Russel J, Elstein S: Comparison of Yuzpe regimen, danazol and mifepristone in oral postcoital contraception. BMJ 1992, 305:927-931.
41. Zulian G, Colombo GF, Molla R: Hormonal postcoital contraception with an ethinyl estradiol-norgestrel combination and two danazol regimens. Eur J Obstet Gynecol Reprod Biol 1990, 37:253-260.
42. Ho PC, Kwan MSW: A prospective randomized comparison of levonorgestrel with the Yuzpe regimen in postcoital contraception. Hum Reprod 1993, 8:389-391.
43. Shirley B, Bundren JC, McKinney S: Levonorgestrel as a postcoital contraceptive. Contraception 1995, 52:277-281.
44. Glasier A, Thong KJ, Dewar M, Mackie M, Baird DT: Mifepristone compared with high dose estrogen and progestogen for emergency postcoital contraception. N Engl J Med 1992, 327:1041-1044.